Candriam SCA’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $5.84M | Sell |
|
|||||
|
2024
Q4 | $8.02M | Sell |
|
|||||
|
2024
Q3 | $9.46M | Hold |
|
|||||
|
2024
Q2 | $9.71M | Sell |
|
|||||
|
2024
Q1 | $34.6M | Buy |
|
|||||
|
2023
Q4 | $22.3M | Sell |
|
|||||
|
2023
Q3 | $14.8M | Sell |
|
|||||
|
2023
Q2 | $17.6M | Hold |
|
|||||
|
2023
Q1 | $17.4M | Buy |
|
|||||
|
2022
Q4 | $23.1M | Hold |
|
|||||
|
2022
Q3 | $24.4M | Sell |
|
|||||
|
2022
Q2 | $20.4M | Sell |
|
|||||
|
2022
Q1 | $23.6M | Buy |
|
|||||
|
2021
Q4 | $23.4M | Hold |
|
|||||
|
2021
Q3 | $18.3M | Hold |
|
|||||
|
2021
Q2 | $10.2M | Buy |
|
|||||
|
2021
Q1 | $7.5M | Hold |
|
|||||
|
2020
Q4 | $7.81M | Buy |
|
|||||
|
2020
Q3 | $3.04M | Buy |
|